MCRB
NASDAQ · Biotechnology
Seres Therapeutics Inc
$7.70
-0.02 (-0.26%)
Open$7.70
Previous Close$7.72
Day High$7.87
Day Low$7.50
52W High$29.98
52W Low$6.53
Volume—
Avg Volume49.8K
Market Cap73.60M
P/E Ratio—
EPS$-5.08
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+234.2% upside
Current
$7.70
$7.70
Target
$25.73
$25.73
$18.91
$25.73 avg
$33.51
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 850.7K | 3.00M | 47.44M |
| Net Income | 6.14M | 19.47M | 5.52M |
| Profit Margin | 721.9% | 685.8% | 11.6% |
| EBITDA | 8.19M | 27.42M | 8.75M |
| Free Cash Flow | — | — | 3.59M |
| Rev Growth | -71.6% | -71.6% | +12.6% |
| Debt/Equity | — | — | 0.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |